Skip to main content

Celera Licenses Proteome s Protein Database

NEW YORK, Sept 14 -

Celera Genomics (NYSE: CRA) has licensed Proteome's BioKnowledge Library for distibution in the Celera Discovery System, Proteome said Thursday.

The research library is comprised of a collection of searchable Proteome Databases that include information about proteins of specific organisms, including human, worm, and yeast.

Financial terms of the deal were not disclosed.

The collaboration will combine Celera's structural and functional genomics information with Proteome's protein information. Proteome said access to the combined data could help in the drug discovery process.

Proteome of Beverly, Mass., is a privately held company that uses its proprietary technology to analyze the human proteome.

Celera of Rockville, Md., has said that it plans to become a leader in industrialized proteomics.

Shares of Celera were up 2, or 2 percent, at 101 7/8 in midday trading.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.